Drugs / Yunzhi Essence
Yunzhi Essence
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT05754801 | Apr 2023 → Mar 2026 overdue | cancer | Chinese University of Hong Kong | Not yet recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Yunzhi Essence | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05754801 ↗ |
| Modality | Traditional medicine (herbal / TCM) | “Chinese Medicine” NCT05754801 ↗ |